Targeting WNT-Driven Cancer Through the Inhibition of Porcupine by LGK974

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1314239110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Targeting the WNT/Β-Catenin Pathway in Primary Ovarian Cancer With the Porcupine Inhibitor WNT974

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2015English

Targeting Ras-Driven Cancer Cell Survival and Invasion Through Selective Inhibition of DOCK1

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

Inhibition of WNT Signaling and Cancer Stem Cells

Oncotarget
Oncology
2011English

Anin Vitrofatty Acylation Assay Reveals a Mechanism for WNT Recognition by the Acyltransferase Porcupine

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Modular Mechanism of WNT Signalling Inhibition by WNT Inhibitory Factor 1

Biophysical Journal
Biophysics
2012English

Canonical WNT Is Inhibited by Targeting One-Carbon Metabolism Through Methotrexate or Methionine Deprivation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Targeting Epigenetics in Sarcomas Through EZH2 Inhibition

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2020English

Up-Regulated NRIP2 in Colorectal Cancer Initiating Cells Modulates the WNT Pathway by Targeting RORβ

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2017English

Targeting Metastasis Through the Inhibition of Interleukin 6 and 8

Breast Cancer Management
OncologyRadiologyNuclear MedicineImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy